Increased expression of IL32-encoded cytokines in RA synovium induces pro-inflammatory cytokine expression, which was highly correlated with the severity of inflammation, suggesting it might be a potential therapeutic target for RA (35). Here, IL32 is linked to rheumatoid arthritis.